JP2022508156A5 - - Google Patents
Info
- Publication number
- JP2022508156A5 JP2022508156A5 JP2021528362A JP2021528362A JP2022508156A5 JP 2022508156 A5 JP2022508156 A5 JP 2022508156A5 JP 2021528362 A JP2021528362 A JP 2021528362A JP 2021528362 A JP2021528362 A JP 2021528362A JP 2022508156 A5 JP2022508156 A5 JP 2022508156A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- virus
- host cells
- recombinant oncolytic
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862770577P | 2018-11-21 | 2018-11-21 | |
| US62/770,577 | 2018-11-21 | ||
| PCT/US2019/062643 WO2020106975A1 (en) | 2018-11-21 | 2019-11-21 | Manufacture of virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022508156A JP2022508156A (ja) | 2022-01-19 |
| JP2022508156A5 true JP2022508156A5 (enExample) | 2022-11-22 |
| JP7625519B2 JP7625519B2 (ja) | 2025-02-03 |
Family
ID=70774620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021528362A Active JP7625519B2 (ja) | 2018-11-21 | 2019-11-21 | ウイルスの製造 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210277363A1 (enExample) |
| EP (1) | EP3884044A4 (enExample) |
| JP (1) | JP7625519B2 (enExample) |
| KR (1) | KR20210093965A (enExample) |
| CN (1) | CN113330111A (enExample) |
| AU (1) | AU2019384164A1 (enExample) |
| CA (1) | CA3120129A1 (enExample) |
| WO (1) | WO2020106975A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116529382A (zh) * | 2020-10-02 | 2023-08-01 | 吉恩勒克斯公司 | 由贴壁细胞在生物反应器中产生病毒 |
| JP2026519561A (ja) * | 2023-05-31 | 2026-06-16 | コーニング インコーポレイテッド | 固定床バイオリアクタにおける改善される細胞回収効率のための方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL131014A0 (en) | 1997-01-31 | 2001-01-28 | Schering Plough Corp | Methods for cultivating cells and propagating viruses |
| DK1520008T3 (da) * | 2002-07-09 | 2012-10-15 | Baxter Int | Medium frit for dyreprotein til dyrkning af celler |
| CN1922308A (zh) * | 2004-02-23 | 2007-02-28 | 克鲁塞尔荷兰公司 | 病毒纯化方法 |
| SI2032592T1 (sl) * | 2006-06-12 | 2013-10-30 | Cytos Biotechnology Ag | Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov |
| AU2007347716B2 (en) * | 2006-09-15 | 2013-06-20 | Medimmune, Llc | MDCK cell lines supporting viral growth to high titers and bioreactor process using the same |
| US8003363B2 (en) * | 2007-05-14 | 2011-08-23 | Bavarian Nordic A/S | Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
| AU2008250596C1 (en) | 2007-05-14 | 2010-11-25 | Bavarian Nordic A/S | Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines |
| KR20110074563A (ko) * | 2008-09-24 | 2011-06-30 | 메디뮨 엘엘씨 | 바이러스의 정제 방법 |
| KR102022952B1 (ko) * | 2011-08-05 | 2019-09-20 | 신라젠(주) | 백시니아 바이러스의 생산을 위한 방법 및 조성물 |
| US10851350B1 (en) * | 2017-06-27 | 2020-12-01 | Genelux Corporation | Bioreactor production of virus from adherent cells |
-
2019
- 2019-11-21 JP JP2021528362A patent/JP7625519B2/ja active Active
- 2019-11-21 WO PCT/US2019/062643 patent/WO2020106975A1/en not_active Ceased
- 2019-11-21 CN CN201980089784.0A patent/CN113330111A/zh active Pending
- 2019-11-21 KR KR1020217018523A patent/KR20210093965A/ko not_active Ceased
- 2019-11-21 CA CA3120129A patent/CA3120129A1/en active Pending
- 2019-11-21 EP EP19887930.6A patent/EP3884044A4/en not_active Withdrawn
- 2019-11-21 AU AU2019384164A patent/AU2019384164A1/en not_active Abandoned
-
2021
- 2021-05-19 US US17/324,756 patent/US20210277363A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5129805B2 (ja) | 細胞培養物から精製水疱性口内炎ウイルスを単離するための精製プロセス | |
| JP2009034115A5 (enExample) | ||
| Cattaneo et al. | Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line | |
| Brinton | Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective interfering particles by resistant cultures | |
| JP2004531220A5 (enExample) | ||
| JP2019504030A5 (enExample) | ||
| JP7648642B2 (ja) | ウイルス調製物から宿主細胞ｄｎａを取り除く方法 | |
| JP2018532411A (ja) | ウイルスフリーの細胞株及びそれを取得する方法 | |
| JP6385559B2 (ja) | 細胞培養体からのポリオウイルスの精製プロセス | |
| Naruse et al. | The polypeptides of mumps virus and their synthesis in infected chick embryo cells | |
| JP2025169249A5 (enExample) | ||
| US20190136206A1 (en) | Virus purification and formulation process | |
| JP2025118611A (ja) | 接着細胞からのウイルスのバイオリアクター生成 | |
| WO2014015816A1 (zh) | 一种去除疫苗中宿主dna的方法 | |
| Holland et al. | Attempts to detect homologous autointerference in vivo with influenza virus and vesicular stomatitis virus | |
| US20260085294A1 (en) | Process for producing a purified rhabdovirus from cell culture | |
| US20240035002A1 (en) | Method for purifying virus | |
| Pelz et al. | Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus | |
| Omar et al. | Syncytium Formation and Inhibition in Semliki-Forest-Virus-Infected Aedes Albopictus Cells at Low pH | |
| Mega et al. | Mutagenic analysis of Hazara nairovirus nontranslated regions during single-and multistep growth identifies both attenuating and functionally critical sequences for virus replication | |
| CN113330111A (zh) | 病毒的制造 | |
| CN111662883A (zh) | 一种制备及纯化溶瘤病毒的方法及重组溶瘤弹状病毒 | |
| CN113817689A (zh) | 慢病毒纯化工艺 | |
| KR101581228B1 (ko) | 바이러스의 증식을 위한 ２-단계 온도 프로파일 | |
| CN105316296A (zh) | 一种纯化腺病毒颗粒的方法 |